Tag: phase 3 trial
October 2, 2019
Soleno Therapeutics Announces Data from Second Planned Data Safety Monitoring Board Review
The outcome of the second meeting was based off data from more than 50 percent of enrolled and treated patients. September 30, 2019
Acasti Pharma Releases Additional Phase 3 Milestones
The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in... September 19, 2019
Rafael Pharma Expands Phase 3 Trial into South Korea
The clinical trials will kick off with an investigator meeting held on Sept. 19 in Seoul. The study is also...
August 19, 2019
Nabriva Notches First FDA Nod for Pneumonia Treatment
The FDA's approval of Xenleta is the first of its kind in almost two decades and will treat community-acquired bacterial... March 6, 2019
Zealand Pharma Doses First Patient in Phase 3 Trial with Dasiglucagon for Treatment of Congenital Hyperinsulinism
Zealand Pharma (NASDAQ:ZEAL) has announced the dosing of the first patient in the first Phase 3 trial to evaluate dasiglucagon... January 22, 2019
Incyte Announces First Patient Treated in Phase 3 Clinical Trial
Incyte (Nasdaq:INCY) today announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the...
November 27, 2018